Tag: Boston Scientific

April 26, 2023

Boston Scientific reported first-quarter sales that exceeded the company’s forecast, saying it gained market share across its businesses as demand for procedures using its medical devices rebounded from a year ago. The company raised its full-year sales and profit forecasts, […]

July 27, 2022

Boston Scientific weathered ongoing COVID-19 and macroeconomic pressures in the second quarter, leading the company to raise its 2022 forecast for organic revenue growth. CEO Michael Mahoney said on a Wednesday earnings call that the company now expects more “durable […]

February 6, 2019

Shares in Boston Scientific (NYSE:BSX) have risen slightly this morning after the medical device maker posted fourth quarter and full year 2018 earnings that topped consensus on Wall Street. The Marlborough, Mass.-based company posted profits of $386 million, or 27¢ […]

November 16, 2018

Boston Scientific (NYSE:BSX) said yesterday that it’s planning a three-year restructuring program that’s slated to cost at least $200 million. The Marlborough, Mass.-based medical device maker said it expects to maintain roughly the same number of workers, although there will […]

September 25, 2017

Boston Scientific (NYSE:BSX) launched today its Resonate implantable cardioverter defibrillator and cardiac resynchronization therapy defibrillator systems with the HeartLogic heart failure diagnostic tool. The devices are approved by the FDA for conditional use in an MRI environment, the company reported. […]

September 11, 2017

Veniti said today it inked a limited global distribution deal with Boston Scientific (NYSE:BSX) for its Vici venous stent. The companies did not release details on which regions Boston Scientific would distribute the stent in or any financial terms of […]